OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

Charity Number: 1195370

REPORT OF THE TRUSTEES AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

(A Charitable Incorporated Organisation)

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

CONTENTS OF THE FINANCIAL STATEMENTS for the year ended 31 March 2025

Page
General Information 1
Report of the Trustees 2
Statement of Financial Activities 3
Balance Sheet 4
Notes to the Financial Statements 5
Independent Examiner’s Report 7

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

GENERAL INFORMATION for the year ended 31 March 2025

TRUSTEES Dr C J Vize
Prof J R O Collin – resigned 23 May 2026
R M J Stewart
D H Verity
Dr F M Quaranta-Leoni – appointed 23 May 2026
Dr E M E Dafgård Kopp – appointed 23 May 2026
ADDRESS c/o Moorfields Eye Hospital
162 City Road
London
EC1V 2PD
CHARITY REGISTRATION NUMBER 1195370
TREASURER Dr E BohmanMD PhD
Director of Oculoplastic and Orbital Services
St. Erik Eye Hospital
Eugeniavägen 12
171 64 Solna
Stockholm
Sweden
INDEPENDENT EXAMINER S J L EllinghamBA FCA DChA
Fawcetts LLP
Chartered Accountants
Windover House
St Ann Street
Salisbury
SP1 2DR

Page 1

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

REPORT OF THE TRUSTEES

for the year ended 31 March 2025

The trustees present their annual report, together with the financial statements of the charity, for the year ended 31 March 2025.

The financial statements have been prepared in accordance with the accounting policies set out in Note 1 to the financial statements and comply with the charity’s governing document, applicable law, and the requirements of the Charities SORP 2019 (FRS 102) and the Charities Act 2011.

STRUCTURE, GOVERNANCE AND MANAGEMENT

European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) is constituted as a Charitable Incorporated Organisation (CIO), as a body corporate under Part 11 of the Charities Act 2011 registered with the Charity Commission for England and Wales on 2 August 2021 (registered number 1195370). The charity is controlled by its governing document, a Deed of Trust.

TRUSTEES

Trustees are legally responsible for the governance and management of the charity. Trustees are responsible for setting strategies and policies and for ensuring these are implemented appropriately. The trustees are assisted in the day-today administration and management of the charity by the society’s treasurer and secretary. The trustees who held office during the year and after the year-end are shown on page 1.

RISK MANAGEMENT

The trustees are responsible for identifying and reviewing the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable safeguards against fraud and error.

OBJECTIVES AND ACTIVITIES

The charity’s objects are to advance the science and art of ophthalmic plastic and reconstructive surgery and to improve the practice and teaching of this subject in Europe and to raise sufficient funds to make fellowship grants.

Public Benefit

The trustees confirm that they have complied with the duty in s17(5) of the Charities Act 2011 to have due regard to the Charity Commission’s guidance on public benefit, including ‘Public Benefit: Reporting’ [PB3].

ACHIEVEMENTS AND PERFORMANCE

The results for the year and financial position of the charity are shown in the attached financial statements. During 2024/25, the charity began transferring net assets, income sources and expenditure from the existing ESOPRS charity (registration number 291040) to ESOPRS CIO. Membership subscriptions of £6,877 (2024: £Nil) were received during the year, together with £5,991 (2024: £Nil) of bank interest. Total expenditure for the year was £2,047 (2024: £Nil). Net income of £10,821 was achieved with £241,685 in unrestricted funds transferred across from the existing ESOPRS charity. The cash position at the end of the year was £249,743 (2024: £Nil) which includes £171,450 (2024: £Nil) held in a specialist charities cash deposit fund. Total unrestricted funds at the year-end amounted to £252,506 (2024: £Nil).

Reserves Policy

The trustees’ policy on the funding of reserves is based upon the Charity Commission document CC19 and therefore recognises the need to hold reserves in order to deal with adverse changes in the levels of income and expenditure in future years. At the year end, total unrestricted funds amounted to £252,506 (2024: £Nil) of which £252,506 (2024: £Nil) related to free reserves.

ON BEHALF OF THE BOARD OF TRUSTEES:

D H Verity

Trustee

Date: 26 August 2026

Page 2

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

STATEMENT OF FINANCIAL ACTIVITIES for the year ended 31 March 2025

2025
2024
Unrestricted Unrestricted
£ £
INCOME AND ENDOWMENTS FROM:
Members’ subscriptions receivable 6,877 -
Bank deposit interest 5,991 -
TOTAL INCOME 12,868 -
EXPENDITURE ON:
Bank charges 202 -
Exchange rate adjustment 58 -
Independent examination fees 1,740 -
Meeting charges 47 -
TOTAL EXPENDITURE 2,047 -
NET INCOME 10,821 -
Total funds brought forward at 1 April 2024 - -
Transfer from ESOPRS (Charity Number: 291040) – Note 4 241,685 -
TOTAL FUNDS CARRIED FORWARD
AT 31 MARCH 2025 252,506 -

Page 3

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

BALANCE SHEET 31 March 2025


FIXED ASSETS
Chain of office
Computer equipment and website development
CURRENT ASSETS
Other debtors
Prepayments and accrued income
Charities deposit fund
Cash at bank
CREDITORS: AMOUNTS DUE WITHIN ONE YEAR
Trade creditors
Accruals
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT LIABILITIES
FUNDS
Unrestricted funds

-
4,503
171,450
78,293
254,246
420
1,320
1,740
2025
£
-
-
-

252,506
252,506
252,506

-
-
-
-
-
-
-
-
2024
£
-
-
-
-
-
-

The trustees confirm, in accordance with the Charitable Incorporated Organisations (General) Regulations 2012, that at the year end the CIO did not have any outstanding guarantees to third parties nor any debts secured on the assets of the CIO.

The financial statements were approved and authorised for issue by the Board of Trustees on 26 August 2026 and were signed on its behalf by:

D H Verity Trustee

Page 4

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

NOTES TO THE FINANCIAL STATEMENTS

for the year ended 31 March 2025

1 ACCOUNTING POLICIES

Basis of preparation of financial statements

The charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) effective 1 January 2019, the Charities Act 2011 and UK Generally Accepted Accounting Practice.

The charity does not meet the definition of a larger charity under the Charity SORP and is therefore exempt from the requirement to prepare a cash flow statement.

The financial statements are prepared on a going concern basis. The financial statements are prepared in Sterling (£) which is the functional currency of the charity.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.

Incoming resources

Members’ subscriptions credited to incoming resources represent subscriptions received in the accounting period.

Resources expended

All expenditure is accounted for on an accruals basis and has been allocated to expenses headings on a direct cost basis.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Tangible fixed assets

Expenditure on fixed assets is capitalised except for expenditure incurred on the replacement of assets of low value with a short life. Repair, renovation and replacement expenditure is written off as expenditure in the profit and loss account. The cost of fixed assets is their purchase cost, together with any incidental costs of acquisition.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Chain of office - 4% on cost Computer equipment and website development - 25% on cost

Exchange rates

Income and expenditure are converted into pounds sterling at the average rate of exchange for the year. Balances are converted at the exchange rate prevailing at the year end.

Page 5

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

NOTES TO THE FINANCIAL STATEMENTS for the year ended 31 March 2025

2 TRUSTEE REMUNERATION AND EXPENSES PAYMENTS

None of the trustees (or any persons connected with them) neither received nor waived any remuneration during the year and none of them were reimbursed any expenses (2024: None).

The charity considers that its key management personnel comprise the trustees. Key management personnel are not remunerated.

There were no employees during the year (2024: None) and consequently there were no staff costs for the year ended 31 March 2025 nor for the year ended 31 March 2024.

3 RELATED PARTY TRANSACTIONS

There were no related party transactions during the year (2024: None).

4 TRANSFER OF ACTIVITIES TO CHARITABLE INCORPORATED ORGANISATION (CIO)

During the year, the trustees commenced the process of transferring the assets, liabilities and activities of the existing unincorporated charity (ESOPRS – charity registration number 291040) to this Charitable Incorporated Organisation (CIO) established to succeed the charity (ESOPRS CIO – charity registration number 1195370). The transfer is being undertaken in stages to ensure an orderly transition and compliance with all legal and regulatory requirements. At the balance sheet date, the transfer had not been fully completed, and certain assets and liabilities remained within the unincorporated charity. The trustees expect the transfer process to be substantially completed during the year ending 31 March 2027, at which point the CIO will assume responsibility for the charity's remaining assets, liabilities and operations.

Page 6

INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF

EUROPEAN SOCIETY OF OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (ESOPRS) CIO

I report to the charity trustees on my examination of the accounts of European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) CIO for the year ended 31 March 2025, which comprise the Statement of Financial Activities, the Balance Sheet and the related notes.

Responsibilities and basis of report

As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).

I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

S J L Ellingham BA FCA DChA Fawcetts LLP Chartered Accountants Windover House St Ann Street Salisbury SP1 2DR

Date: 26 August 2026

Page 7